Latest Articles

Publication Date
Fermanagh woman fighting for endometriosis support - The Fermanagh Herald

Fermanagh woman fighting for endometriosis support The Fermanagh Herald

Published: Oct. 2, 2025, 4:10 p.m.
Women harmed by surgeon Daniel Hay say they have 'no closure' - BBC

Women harmed by surgeon Daniel Hay say they have 'no closure' BBC

Published: Oct. 2, 2025, 3:33 a.m.
‘Severe period pain – it’s not normal’ - The Namibian -

‘Severe period pain – it’s not normal’ The Namibian -

Published: Oct. 1, 2025, 11 a.m.
Study Explores Link Between Irisin Hormone Levels and Endometrial Cancer Progression - geneonline.com

Study Explores Link Between Irisin Hormone Levels and Endometrial Cancer Progression geneonline.com

Published: Oct. 1, 2025, 12:08 a.m.
Gesynta Pharma receives UK approval for a Phase 2 trial of vipoglanstat in endometriosis - beQuoted

Gesynta Pharma receives UK approval for a Phase 2 trial of vipoglanstat in endometriosis beQuoted

Published: Sept. 30, 2025, 8 a.m.
'Severe period pain – it's not normal' - Yahoo News Canada

'Severe period pain – it's not normal' Yahoo News Canada

Published: Sept. 30, 2025, 6:05 a.m.
Genescience Pharmaceuticals divulges new 17β-HSD1 inhibitors - BioWorld MedTech

Genescience Pharmaceuticals divulges new 17β-HSD1 inhibitors BioWorld MedTech

Published: Sept. 29, 2025, 1 p.m.
I was in constant pain for a decade but everyone told me it was normal - Liverpool Echo

I was in constant pain for a decade but everyone told me it was normal Liverpool Echo

Published: Sept. 29, 2025, 4 a.m.
Depo Provera Lawsuit Settlement | Sept 2025 Litigation Update - Lawsuit Information Center

Depo Provera Lawsuit Settlement | Sept 2025 Litigation Update Lawsuit Information Center

Published: Sept. 26, 2025, 5:53 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia

Published: Sept. 26, 2025, 11:03 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!